Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus

The present study is aimed to evaluate and compare the efficacy and safety of tenofovir (TDF) and telbivudine (TBV) in interrupting hepatitis B virus (HBV) mother-to-child transmission (MTCT), and to provide evidence-based treatment options to clinicians and patients. Hepatitis B e-antigen (HBeAg)-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Bo, Lv, Xiaojing, Zhao, Zhiying, Chen, Liwen, Chen, Xiuli, Li, Congjie, Li, Suwen, Dai, Erhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568400/
https://www.ncbi.nlm.nih.gov/pubmed/34871254
http://dx.doi.org/10.1097/MD.0000000000027695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568400/
https://www.ncbi.nlm.nih.gov/pubmed/34871254
http://dx.doi.org/10.1097/MD.0000000000027695

Ejemplares similares